Globally, the World Health Organization (WHO) collects mortality data, including the prevalence and causes of suicide, for all member states. In early 2013, after declaring rising suicide rates a "global public health crisis," they advocated for evidence-based strategies to prevent suicide worldwide. The lifetime suicide rate for people with schizophrenia is approximately 10%. Suicide is the biggest factor in reducing life expectancy for these people. The only reliable protective factor for suicide in patients with schizophrenia is the provision and adherence to comprehensive treatment. Prevention of suicidal behavior in schizophrenia should include identifying at-risk patients as well as providing the best possible therapy and care. Suicide and suicide attempts are significantly more common in schizophrenia than in the general population. General estimates are that a relatively large percentage of people with schizophrenia will eventually complete suicide, and that attempts are made two to five times more often.
The purpose of this report is to investigate and provide a worldwide overview of suicidal behavior in individuals diagnosed with schizophrenia.
Materials and methods: In the present report, scientific publications reflecting the characteristics of suicide attempts in patients with schizophrenia were reviewed and analyzed. Documentary and analytical method were used.
Conclusions: After the research of the scientific literature, the following conclusions can be made:
Balhara, Y. P., & Verma, R. (2012). Schizophrenia and suicide East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 22(3), 126–133.
Bateman, K., Hansen, L., Turkington, D., & Kingdon, D. (2007). Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial. Suicide & life-threatening behavior, 37(3), 284–290. https://doi.org/10.1521/suli.2007.37.3.284
Bleuler, E. Dementia Praecox: oder Gruppe der Schizophrenien; Franz Deuticke: Leipzig, Germany, 1911. https://www.researchgate.net/publication/51062752_Eugen_Bleuler's_Dementia_Praecox_or_the_Group_of_Schizophrenias_1911_A_Centenary_Appreciation_and_Reconsideration
Díaz-Fernández, S., Frías-Ortiz, D. F., & Fernández-Miranda, J. J. (2020). Suicide attempts in people with schizophrenia before and after participating in an intensive case managed community program: A 20-year follow-up. Psychiatry research, 287, 112479. https://doi.org/10.1016/j.psychres.2019.112479
Harkavy-Friedman, J. M., & Nelson, E. (1997). Management of the suicidal patient with schizophrenia.. The Psychiatric clinics of North America, 20(3), 625–640. https://doi.org/10.1016/s0193-953x(05)70334-8
Harkavy-Friedman, J. M., & Nelson, E. A. (1997). Assessment and intervention for the suicidal patient with schizophrenia. The Psychiatric quarterly, 68(4), 361–375. https://doi.org/10.1023/a:1025447115067
Harmer, B., Lee, S., Duong, T. V. H., & Saadabadi, A. (2023). Suicidal Ideation. In StatPearls. StatPearls Publishing.
Kraepelin, E. Psychiatrische Randbemerkungen zur Zeitgeschichte. Suddeutsch. Monatshefte 1919, 2, 171–183. https://www.abebooks.com/first-edition/Psychiatrische-Randbemerkungen-Zeitgeschichte-S%C3%BCddeutsche-Monatshefte-Heft/30955182756/bd
McGirr, A., & Turecki, G. (2008). What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions. Schizophrenia research, 98(1-3), 217–224. https://doi.org/10.1016/j.schres.2007.09.009
Rennie, T.A.C. Follow-up study of five hundred patients with schizophrenia admitted to the hospital from 1913 to 1923. Arch. Neurol. Psychiatry 1939, 42, 877–891. https://jamanetwork.com/journals/archneurpsyc/article-abstract/648245
Roy, A., & Pompili, M. (2009). Management of schizophrenia with suicide risk. The Psychiatric clinics of North America, 32(4), 863–883. https://doi.org/10.1016/j.psc.2009.08.005.
Sartorius, N., Jablensky, A., Korten, A., Ernberg, G., Anker, M., Cooper, J. E., & Day, R. (1986). Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychological medicine, 16(4), 909–928. https://doi.org/10.1017/s0033291700011910
Sher, L., & Kahn, R. S. (2019). Suicide in Schizophrenia: An Educational Overview. Medicina (Kaunas, Lithuania), 55(7), 361. https://doi.org/10.3390/medicina55070361
Siris S. G. (2001). Suicide and schizophrenia. Journal of psychopharmacology (Oxford, England), 15(2), 127–135. https://doi.org/10.1177/026988110101500209
Tiihonen, J., Wahlbeck, K., Lönnqvist, J., Klaukka, T., Ioannidis, J. P., Volavka, J., & Haukka, J. (2006). Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ (Clinical research ed.), 333(7561), 224. https://doi.org/10.1136/bmj.38881.382755.2F
Wasserman, D., Carli, V., Iosue, M., Javed, A., & Herrman, H. (2021). Suicide prevention in psychiatric patients. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists, 13(3), e12450. https://doi.org/10.1111/appy.12450
White, J., Gray, R., & Jones, M. (2009). The development of the serious mental illness physical Health Improvement Profile. Journal of psychiatric and mental health nursing, 16(5), 493–498. https://doi.org/10.1111/j.1365-2850.2009.01375.x
Zisook, S., Byrd, D., Kuck, J., & Jeste, D. V. (1995). Command hallucinations in outpatients with schizophrenia. The Journal of clinical psychiatry, 56(10), 462–465.
